NFE2L3 is highly expressed in Hodgkin’s lymphoma, pancreatic cancer, hepatocellular carcinoma, gastric cancer, colorectal cancer and other malignant tumours [31–37]. The gene discussed is NFE2L3; the disease is hepatocellular carcinoma.